Dr Jerald Sadoff | Senior Advisor Vaccine Development
Janssen Infectious Diseases and Vaccines

Dr Jerald Sadoff, Senior Advisor Vaccine Development, Janssen Infectious Diseases and Vaccines

Dr Jerald C. Sadoff is currently the Head of Early Development of the Crucell Vaccine Institute which is the Center of Excellence for Vaccine Development for Johnson & Johnson Companies Worldwide. Dr. Sadoff has spent his entire career developing vaccines against a large number of bacterial, viral and parasitic diseases, 11 of which have been licensed for human use and several currently are in Phase IIB and Phase III clinical trials. He currently serves on several IPCAVD Scientific Advisory Boards for NIH sponsored HIV vaccine efforts and is on the NIAID AIDS Vaccine Research Working Group. Over the last 35 years, he has authored over 350 articles, book chapters, and abstracts and has 18 issued patents


Agenda Day 1 @ 11:40

Chair’s opening remarks

Agenda Day 2 @ 2:15

Developing vaccines for viral infections: Addressing HIV and Zika vaccine development

  • Results of Ph1b study for HIV vaccine
  • Moving into Ph11a proof of concept studies
  • Results of Zika pre-clinical studies
  • Preparing for Zika first in human trials
  • Has interest in Zika diminished? Impact on vaccine development

back to speakers